Roland Chen

3.3k total citations
81 papers, 2.6k citations indexed

About

Roland Chen is a scholar working on Biomedical Engineering, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Roland Chen has authored 81 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Biomedical Engineering, 28 papers in Surgery and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Roland Chen's work include Diabetes Treatment and Management (15 papers), Additive Manufacturing and 3D Printing Technologies (15 papers) and Thyroid and Parathyroid Surgery (10 papers). Roland Chen is often cited by papers focused on Diabetes Treatment and Management (15 papers), Additive Manufacturing and 3D Printing Technologies (15 papers) and Thyroid and Parathyroid Surgery (10 papers). Roland Chen collaborates with scholars based in United States, China and France. Roland Chen's co-authors include Albert J. Shih, Jeffrey Wensman, Elsie Allen, Jia Li, Robert Frederich, Mäher S. Amer, Priscilla Hollander, Niklas Berglind, Shaista Malik and Nathan D. Wong and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Roland Chen

80 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roland Chen United States	27	884	769	613	470	389	81	2.6k
Meng Dai China	29	409 0.5×	467 0.6×	471 0.8×	80 0.2×	385 1.0×	137	2.6k
Shigeki Morita Japan	30	204 0.2×	617 0.8×	1.1k 1.8×	169 0.4×	692 1.8×	179	2.8k
Omar Omar Sweden	32	188 0.2×	1.9k 2.4×	1.0k 1.7×	89 0.2×	107 0.3×	90	4.0k
Yong Sang Lee South Korea	26	1.7k 1.9×	175 0.2×	2.1k 3.4×	247 0.5×	117 0.3×	166	3.6k
Tae‐Won Lee South Korea	25	165 0.2×	331 0.4×	187 0.3×	196 0.4×	154 0.4×	125	2.9k
Adriana C. Panayi United States	34	291 0.3×	891 1.2×	1.3k 2.1×	113 0.2×	184 0.5×	227	4.6k
Zhijun Pan China	32	207 0.2×	391 0.5×	983 1.6×	48 0.1×	101 0.3×	117	3.1k
Yohei Oda Japan	25	196 0.2×	119 0.2×	170 0.3×	230 0.5×	291 0.7×	87	2.1k
Sang Jun Park South Korea	41	68 0.1×	1.2k 1.5×	429 0.7×	218 0.5×	100 0.3×	251	5.4k
Seung‐Pyo Lee South Korea	31	244 0.3×	451 0.6×	638 1.0×	41 0.1×	2.0k 5.2×	242	3.8k

Countries citing papers authored by Roland Chen

Since Specialization

Citations

This map shows the geographic impact of Roland Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Chen more than expected).

Fields of papers citing papers by Roland Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Chen. The network helps show where Roland Chen may publish in the future.

Co-authorship network of co-authors of Roland Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Chen. A scholar is included among the top collaborators of Roland Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Chen. Roland Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Awad, Atheer, Álvaro Goyanes, Abdul W. Basit, et al.. (2022). A Review of State-of-the-Art on Enabling Additive Manufacturing Processes for Precision Medicine. Journal of Manufacturing Science and Engineering. 145(1). 33 indexed citations

Chang, Yu‐Chung, Yao Chen, Cheng Hao, et al.. (2019). No Such Thing as Trash: A 3D-Printable Polymer Composite Composed of Oil-Extracted Spent Coffee Grounds and Polylactic Acid with Enhanced Impact Toughness. ACS Sustainable Chemistry & Engineering. 7(18). 15304–15310. 62 indexed citations

Li, Hui, Roland Chen, Yuxuan Tang, William J. Meurer, & Albert J. Shih. (2017). An experimental study and finite element modeling of head and neck cooling for brain hypothermia. Journal of Thermal Biology. 71. 99–111. 8 indexed citations

Chen, Roland & Albert J. Shih. (2013). Multi-modality gellan gum-based tissue-mimicking phantom with targeted mechanical, electrical, and thermal properties. Physics in Medicine and Biology. 58(16). 5511–5525. 49 indexed citations

Frederich, Robert, Robert McNeill, Niklas Berglind, Douglas Fleming, & Roland Chen. (2012). The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial. Diabetology & Metabolic Syndrome. 4(1). 36–36. 58 indexed citations

Chen, Roland, et al.. (2012). Electrosurgical Vessel Sealing Tissue Temperature: Experimental Measurement and Finite Element Modeling. IEEE Transactions on Biomedical Engineering. 60(2). 453–460. 33 indexed citations

Karyekar, Chetan S., Mark Donovan, Elsie Allen, et al.. (2011). Efficacy and Safety of Saxagliptin Combination Therapy in US Patients with Type 2 Diabetes. Postgraduate Medicine. 123(4). 63–70. 14 indexed citations

Scirica, Benjamin M., Deepak L. Bhatt, Eugene Braunwald, et al.. (2011). The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study. American Heart Journal. 162(5). 818–825.e6. 90 indexed citations

Frederich, Robert, John H. Alexander, Fred T. Fiedorek, et al.. (2010). A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes. Postgraduate Medicine. 122(3). 16–27. 182 indexed citations

10.

Frederich, Robert, Mark Donovan, Niklas Berglind, et al.. (2009). Abstract 978: Cardiovascular Safety of Saxagliptin as Mono- or Add-on Therapy in Patients With Type 2 Diabetes. Circulation. 120. 2 indexed citations

11.

Maheux, Pierre, Elsie Allen, Shoba Ravichandran, James F. List, & Roland Chen. (2009). Saxagliptin added to a thiazolidinedione, metformin or a sulphonylurea improves glycaemic control in patients with inadequately controlled type 2 diabetes mellitus. 3 indexed citations

12.

Coyle, Doug, Roger A. Rodby, Steven Soroka, et al.. (2007). Cost-Effectiveness of Irbesartan 300 mg Given Early Versus Late in Patients with Hypertension and a History of Type 2 Diabetes and Renal Disease: A Canadian Perspective. Clinical Therapeutics. 29(7). 1508–1523. 13 indexed citations

13.

Palmer, Andrew, William J. Valentine, Daniel M. Tucker, et al.. (2006). A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension. Current Medical Research and Opinion. 22(11). 2095–2100. 8 indexed citations

14.

Malik, Shaista, et al.. (2006). Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Research and Clinical Practice. 77(1). 126–133. 69 indexed citations

15.

Kolm, Paul, Emir Veledar, Zefeng Zhang, et al.. (2005). Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 46(5). 761–769. 85 indexed citations

16.

Weintraub, William S., Elizabeth M. Mahoney, Shamir R. Mehta, et al.. (2004). 1137-77 Long-term cost-effectiveness of clopidogrel in patients having percutaneous coronary intervention early after acute coronary syndrome: Results from PCI-CURE. Journal of the American College of Cardiology. 43(5). A296–A296. 3 indexed citations

17.

Havranek, Edward P., Teresa A. Simon, Gilbert L’Italien, et al.. (2004). The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. Journal of Cardiac Failure. 10(4). 339–343. 12 indexed citations

18.

Chen, Roland, et al.. (2004). Importance of ray-trace modeling in the discovery of Thunder Horse North Field, Gulf of Mexico. The Leading Edge. 23(1). 68–70. 5 indexed citations

19.

Wong, Nathan D., et al.. (2004). 820-2 Risk of cardiovascular disease in US persons with metabolic risk factors, diabetes, and elevated C-reactive protein. Journal of the American College of Cardiology. 43(5). A486–A486.

20.

Palmer, Andrew, Lieven Annemans, Stéphane Roze, et al.. (2004). Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria. Kidney International. 67(93). S52–S54. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact